This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Viracta Subsidiary, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: David Slack - Innovator in Pharmaceutical Development
Introduction
David Slack is a notable inventor based in Rancho Santa Fe, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications. His work focuses on creating effective treatments for serious health conditions.
Latest Patents
David Slack holds a patent for an HDAC inhibitor solid-state form. The patent details various solid-state forms of N-hydroxy 2-{6-[(6-fluoro-quinolin-2-ylmethyl)-amino]-3-aza-bicyclo[3.1.0]hex-3-yl}pyrimidine-5-carboxamide. This compound is particularly useful in the preparation of pharmaceutical compositions and dosage forms aimed at treating cancer, immune disorders, and inflammation.
Career Highlights
David Slack is currently associated with Viracta Subsidiary, Inc., where he continues to advance his research and development efforts. His innovative approach has positioned him as a key player in the pharmaceutical industry, contributing to the creation of effective therapeutic solutions.
Collaborations
David has collaborated with notable colleagues, including Xiaohu Deng and Stewart Jones. Their combined expertise enhances the research and development processes within their organization.
Conclusion
David Slack's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific advancements. His work in developing HDAC inhibitors showcases the potential for new treatments in critical areas of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile